Get the full picture
Sign in to uncover key details.
Sonoma Biotherapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 E Jamie Ct Ste 250, South San Franci...Phone Number
(415) 992-6245Website
www.sonomabio.comRevenue
<$5 MillionIndustry
About Sonoma Biotherapeutics
Sonoma Biotherapeutics is focused on developing living cell therapies aimed at restoring balance to the immune system to potentially cure autoimmune and inflammatory diseases. The company is a pioneer in regulatory T cell (Treg) biology and is currently evaluating its lead Treg program in clinical trials. Founded by experts in the field, Sonoma Biotherapeutics is committed to improving the lives of patients suffering from these conditions. Their innovative approach is grounded in decades of research and collaboration, underscoring their mission to bring hope to affected individuals.Explore more
Sonoma Biotherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Sonoma Biotherapeutics
Compare insights from companies similar to Sonoma Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sonoma Biotherapeutics Tech Stack
A closer look at the technologies used by Sonoma Biotherapeutics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sonoma Biotherapeutics
Sign Up For FreeTo access detailed company insights
Sonoma Biotherapeutics is focused on developing living cell therapies aimed at restoring balance to the immune system to potentially cure autoimmune and inflammatory diseases. The company is a pioneer in regulatory T cell (Treg) biology and is currently evaluating its lead Treg program in clinical trials. Founded by experts in the field, Sonoma Bio... Read More
